Chronic treatment with statins increases the availability of selenium in the antioxidant defence systems of hemodialysis patients
- 31 January 2010
- journal article
- research article
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 24 (1) , 27-30
- https://doi.org/10.1016/j.jtemb.2009.06.005
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout miceLife Sciences, 2008
- Activatable Magnetic Resonance Imaging Agent Reports Myeloperoxidase Activity in Healing Infarcts and Noninvasively Detects the Antiinflammatory Effects of Atorvastatin on Ischemia-Reperfusion InjuryCirculation, 2008
- Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effectsKidney International, 2006
- N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activityKidney International, 2006
- Prognosis at 6 Months for Coronary and Cerebrovascular Patients: Impact of Antiplatelet Agents and Statins: Results from the Prevenir III StudyCardiovascular Drugs and Therapy, 2006
- The effect of different dialysis membranes on oxidative stress and selenium statusClinica Chimica Acta; International Journal of Clinical Chemistry, 2004
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Oxidant stress in hemodialysis: Prevention and treatment strategiesKidney International, 2000
- Hemodialysis with Regenerated Cellulosic Membranes Does Not Reduce Plasma Selenium Levels in Chronic Uremic PatientsArtificial Organs, 1995
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976